Extended interval screening by the Diabetic RetinaScreen Programme in Ireland

Health Information and Quality Authority (HIQA)
Record ID 32018001671
Authors' objectives: Diabetic retinopathy is a microvascular complication of diabetes mellitus and is a common cause of vision impairment and sight loss. Diabetic retinopathy screening programmes can prevent the progression of sight-threatening diabetic retinopathy (STDR) by timely detection and treatment of cases. Diabetic RetinaScreen is a government-funded programme providing free diabetic retinopathy screening to all persons with diabetes aged 12 years and older on the Diabetic RetinaScreen register. Annual screening of people with diabetes is current practice. However, in line with international practice, it has been proposed that two year screening intervals should be introduced for those at low risk of retinopathy progression and who have demonstrated compliance with the programme.
Project Status: Completed
Year Published: 2021
Requestor: The National Screening Advisory Committee (NSAC)
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Ireland
MeSH Terms
  • Diabetic Retinopathy
  • Mass Screening
  • Time Factors
  • Risk Factors
  • Diabetes Mellitus, Type 2
  • Diabetic Retinopathy
  • Screening
Organisation Name: Health Information and Quality Authority (HIQA)
Contact Address: Health Information and Quality Authority, George's Court, George's Lane,Smithfield, Dublin 7. PH : + 353 (01) 814 7464
Contact Name: info@hiqa.ie
Contact Email: info@hiqa.ie
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.